Related Experiment Video
Updated: May 30, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Thyroid cancer: emerging role for targeted therapies
Jennifer A Sipos1, Manisha H Shah
1Division of Endocrinology, The Ohio State University, Columbus, OH, USA.
Therapeutic Advances in Medical Oncology
|July 27, 2011
Summary
Targeted therapies show promise for aggressive thyroid cancers, including differentiated thyroid cancer (DTC) resistant to radioactive iodine, medullary thyroid carcinoma (MTC), and anaplastic thyroid cancer (ATC). Clinical trials are evaluating these novel treatments for improved patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Thyroid cancer exhibits diverse histology and clinical behavior, ranging from indolent to highly lethal.
- Standard treatments like surgery and radioactive iodine are effective for most differentiated thyroid cancers (DTC), but iodine-resistant DTC, medullary thyroid carcinoma (MTC), and anaplastic thyroid cancer (ATC) present significant challenges with limited therapeutic options.
- Despite well-characterized genetic defects in MTC and ATC, effective systemic therapies remain elusive.
Purpose of the Study:
- To review recent advancements in understanding thyroid cancer pathogenesis.
- To summarize the outcomes of clinical trials investigating targeted molecular therapies for various thyroid cancer subtypes.
- To highlight the potential of these new therapies in setting future treatment standards.
Main Methods:
- Review of recent scientific literature on thyroid cancer pathogenesis.
- Analysis of data from numerous clinical trials conducted over the past five years.
- Focus on targeted therapies directed at critical signaling pathways and angiogenesis.
Main Results:
- Increased understanding of papillary thyroid carcinoma and ATC pathogenesis has driven the development of targeted therapies.
- Tyrosine kinase inhibitors targeting known defects in MTC are under clinical investigation.
- Clinical trials involving targeted therapies for iodine-refractory DTC, MTC, and ATC have yielded promising results.
Conclusions:
- Targeted molecular therapies represent a significant breakthrough in managing advanced and refractory thyroid cancers.
- Ongoing clinical trials offer hope for establishing new treatment paradigms for patients with progressive thyroid cancer.
- Further research into targeted therapies is crucial for improving the prognosis of patients with challenging thyroid cancer subtypes.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...